Saturday, May 2, 2020
- 11:00AM-12:00PM
-
Abstract Number: 007
Dense Genotyping of Immunologic Loci Identifies CXCR4 as a Novel Susceptibility Locus for Systemic Juvenile Idiopathic Arthritis
Plenary Abstracts Session 3- 11:00AM-12:00PM
-
Abstract Number: 009
Emapalumab (Anti-Interferon-Gamma Monoclonal Antibody) in Patients with Macrophage Activation Syndrome (MAS) Complicating Systemic Juvenile Idiopathic Arthritis (sJIA)
Plenary Abstracts Session 3- 11:00AM-12:00PM
-
Abstract Number: 010
Experience with and Management of HLH-like Toxicities Following Chimeric Antigen Receptor T-Cell Therapy for Treatment of Relapsed/Refractory Pre-B ALL
Plenary Abstracts Session 3- 11:00AM-12:00PM
-
Abstract Number: 008
Incidence and Risk Factors of Hypogammaglobulinemia and Infectious Complications Associated with Rituximab Use in Pediatric Rheumatic Diseases
Plenary Abstracts Session 3- 4:15PM-5:15PM
-
Abstract Number: 165
A Massively Parallel Reporter Assay Screen of Genetic Variants on JIA Haplotypes Reveals Variants Associated with Altered Function of an Intergenic Enhancer in the HLA Class II Locus
Poster Session 3- 4:15PM-5:15PM
-
Abstract Number: 188
A New Multidisciplinary Pediatric SLE Clinic in a Large Urban Care Center: Feasibility, Patient Satisfaction, and Quality After One Year
Poster Session 3- 4:15PM-5:15PM
-
Abstract Number: 184
A Survey of Uveitis Knowledge Among Juvenile Arthritis Patients and Parents
Poster Session 3- 4:15PM-5:15PM
-
Abstract Number: 119
Actual Medication Usage of Patients with Juvenile Onset Systemic Lupus Erythematosus Using Japanese Health Insurance Database
Poster Session 3- 4:15PM-5:15PM
-
Abstract Number: 186
Anthropometric Assessment and Food Intake of Parents of Pediatric Patients with Chronic Rheumatic Diseases
Poster Session 3- 4:15PM-5:15PM
-
Abstract Number: 145
Anti-Citrullinated Protein Antibodies (ACPA) and Bony Erosions in Polyarticular JIA
Poster Session 3- 4:15PM-5:15PM
-
Abstract Number: 163
Anti-Dense Fine Speckled (DFS) Autoantibodies in Autoinflammatory Vasculopathies
Poster Session 3- 4:15PM-5:15PM
-
Abstract Number: 130
Anti-Ro/SSA Is Associated with Progression to End-Stage Renal Disease in Anti-dsDNA Positive Lupus Nephritis